COVID‑19 and pharmacogenomics: an association that warrants comprehensive assessment

As treatments for COVID-19 are explored, it’s becoming clear there is a great deal of variability in the presentation of the disease. And as multiple medications are being investigated for use, it’s clear that pharmacogenomics should play an essential part in prescribing, especially for those over 65 and already utilizing multiple medications. A recent article in the Journal of Precision Medicine lays out the case.